PharmiNews

Directory of Pharma Companies and News

Company Profile

Karus Therapeutics

Karus Therapeutics logo
Category
Karus Therapeutics, based in Oxfordshire, UK, is a clinical-stage biopharmaceutical company developing precision medicines for cancer. The Company’s orally-active, small molecule drugs combine targeted and immunotherapeutic mechanisms of action for the treatment of cancer patients with clear unmet medical need and limited treatment options. Karus has two small molecule clinical candidates in Phase I studies, KA2507 and KA2237. The Company is privately-held and is supported by a world-leading syndicate of life science investors from the US and Europe: SV Health Investors, New Leaf Ventures, Novo A/S and IP Group.
Keywords:
0 results
Brought to you by PharmiWeb.com - Latest Jobs in Pharma